Literature DB >> 10905532

Risk factors for second urinary tract infection among college women.

B Foxman1, B Gillespie, J Koopman, L Zhang, K Palin, P Tallman, J V Marsh, S Spear, J D Sobel, M J Marty, C F Marrs.   

Abstract

To better understand the etiology of recurrent urinary tract infection (UTI), the authors followed a cohort of 285 female college students with first UTI for 6 months or until second UTI. A first UTI due to Escherichia coli was followed by a second UTI three times more often than was a non-E. coli first UTI (24 vs. 8%; p = 0.02). In a logistic regression analysis limited to the 224 women from the University of Michigan Health Service and the University of Texas at Austin Health Service from September 1992 to December 1994, with a first UTI due to E. coli, vaginal intercourse increased the risk of a second UTI with both a different (odds ratio (OR) = 1.60, 95% confidence interval (CI): 1.19, 2.15) and the same (OR = 1.37, 95% CI: 0.91, 2.07) uropathogen, as did using a diaphragm, cervical cap, and/or spermicide (same uropathogen: OR = 1.53, 95% CI: 0.95, 2.47; different uropathogen: OR = 1.77, 95% CI: 1.22, 2.58). Condom use decreased the risk of a second UTI caused by a different uropathogen (OR = 0.68, 95% CI: 0.48, 0.99) but had no effect on a second UTI caused by the same E. coli (OR = 0.99; 95% CI: 0.66, 1.50). Type or duration of treatment was not associated with a second UTI. Although the risk of second UTI is strongly influenced by sexual behavior, women with a first UTI caused by E. coli are more likely than are those with a non-E. coli first UTI to have a second UTI within 6 months.

Entities:  

Mesh:

Year:  2000        PMID: 10905532     DOI: 10.1093/oxfordjournals.aje.a010170

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  79 in total

1.  Pathogenesis of Urinary Tract Infection: the Role of Sexual Behavior and Sexual Transmission.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial.

Authors:  Ann E Stapleton; James Dziura; Thomas M Hooton; Marsha E Cox; Yuliya Yarova-Yarovaya; Shu Chen; Kalpana Gupta
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 4.  [Treatment and prophylaxis of recurrent urinary tract infections].

Authors:  B Banas; B K Krämer
Journal:  Internist (Berl)       Date:  2005-12       Impact factor: 0.743

5.  Subsequent infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization.

Authors:  Anna Lindblom; Nahid Karami; Tim Magnusson; Christina Åhrén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-23       Impact factor: 3.267

Review 6.  Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis.

Authors:  Brian Becknell; Andrew Schwaderer; David S Hains; John David Spencer
Journal:  Nat Rev Nephrol       Date:  2015-07-07       Impact factor: 28.314

7.  One size doesn't fit all: unraveling the diversity of factors and interactions that drive E. coli urovirulence.

Authors:  Henry L Schreiber; Caitlin N Spaulding; Karen W Dodson; Jonathan Livny; Scott J Hultgren
Journal:  Ann Transl Med       Date:  2017-01

Review 8.  Urinary tract infections in adult general practice patients.

Authors:  Eva Hummers-Pradier; Michael M Kochen
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

Review 9.  The role of probiotics in women with recurrent urinary tract infections.

Authors:  Turgay Akgül; Tolga Karakan
Journal:  Turk J Urol       Date:  2018-09-01

10.  Prevention of recurrent urinary tract infections by intravesical administration of heparin: a pilot study.

Authors:  Tova Ablove; Manish Patankar; Songwon Seo
Journal:  Ther Adv Urol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.